Metropolitan Life Insurance Company (MetLife)’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-8,611
| Closed | -$1.21M | – | 2602 |
|
|
2018
Q4 | $1.21M | Buy |
8,611
+57
| +0.7% | +$7.98K | 0.02% | 688 |
|
|
2018
Q3 | $1.46M | Hold |
8,554
| – | – | 0.02% | 704 |
|
|
2018
Q2 | $1.48M | Buy |
8,554
+1,517
| +22% | +$263K | 0.02% | 701 |
|
|
2018
Q1 | $812K | Sell |
7,037
-274
| -4% | -$31.6K | 0.01% | 997 |
|
|
2017
Q4 | $615K | Sell |
7,311
-8,071
| -52% | -$679K | 0.01% | 1146 |
|
|
2017
Q3 | $1.42M | Buy |
15,382
+1,726
| +13% | +$159K | 0.01% | 1071 |
|
|
2017
Q2 | $1.1M | Buy |
13,656
+3,097
| +29% | +$248K | 0.01% | 1191 |
|
|
2017
Q1 | $444K | Hold |
10,559
| – | – | ﹤0.01% | 1736 |
|
|
2016
Q4 | $339K | Sell |
10,559
-3,863
| -27% | -$124K | ﹤0.01% | 2014 |
|
|
2016
Q3 | $378K | Buy |
14,422
+3,863
| +37% | +$101K | ﹤0.01% | 1894 |
|
|
2016
Q2 | $245K | Buy |
10,559
+3,588
| +51% | +$83.3K | ﹤0.01% | 2190 |
|
|
2016
Q1 | $191K | Hold |
6,971
| – | – | ﹤0.01% | 2207 |
|
|
2015
Q4 | $198K | Buy |
+6,971
| New | +$198K | ﹤0.01% | 2278 |
|